Resident Summit To Focus on Interactions With Drug Industry

At APA’s fall Institute on Psychiatric Services, residents are invited to attend a summit on interactions with the pharmaceutical industry. As many residents know, physician contact with the pharmaceutical industry is frequent during residency training.

Michael Jibson, M.D., director of psychiatry residency training at the University of Michigan in Ann Arbor, has created a curriculum to help residents construct an ethical framework in which to evaluate these interactions. The session, titled “An Ethical Framework for Physician Interactions With the Pharmaceutical Industry,” will be held Friday, October 11, from 1:30 p.m. to 3 p.m. in Parlor B, sixth floor, Palmer House Hilton.

The session is intended to educate residents about the nature and impact of the pharmaceutical industry on the practice of medicine, examine the nature of interactions between physicians and industry, clarify the ethical issues involved in physician-industry interactions, and assist residents in evaluating the ethical and clinical implications of physician-industry interactions.

The session is designed to avoid a polemic approach in favor of a balanced consideration of the issues involved. The goal is for residents to develop informed, clear, and thoughtful standards for these interactions. Participants will also have an opportunity to discuss their experiences and ask questions.

More information is available by contacting Nancy Delanoche by phone at (202) 682-6126 or by e-mail at [email protected]. ▪